|
Name |
2-Ethyl-p-xylene
|
| Molecular Formula | C10H14 | |
| IUPAC Name* |
2-ethyl-1,4-dimethylbenzene
|
|
| SMILES |
CCC1=C(C=CC(=C1)C)C
|
|
| InChI |
InChI=1S/C10H14/c1-4-10-7-8(2)5-6-9(10)3/h5-7H,4H2,1-3H3
|
|
| InChIKey |
AXIUBBVSOWPLDA-UHFFFAOYSA-N
|
|
| Synonyms |
2-Ethyl-p-xylene; 1758-88-9; 2-ETHYL-1,4-DIMETHYLBENZENE; 1,4-Dimethyl-2-ethylbenzene; Benzene, 2-ethyl-1,4-dimethyl-; p-Xylene, 2-ethyl-; 2,5-Dimethylethylbenzene; 1-Ethyl-2,5-dimethylbenzene; NSC74186; EINECS 217-158-3; NSC 74186; 1,4-Dimethyl-2-ethyl benzene; 1,4-dimethyl-2-ethyl-benzene; DTXSID0061951; BAA75888; ZINC1699570; MFCD00059233; NSC-74186; AKOS016846194; DS-2976; CS-0206595; E0279; FT-0690895; T71937; A881547; Q63391958
|
|
| CAS | 1758-88-9 | |
| PubChem CID | 15653 | |
| ChEMBL ID | NA |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 134.22 | ALogp: | 3.4 |
| HBD: | 0 | HBA: | 0 |
| Rotatable Bonds: | 1 | Lipinski's rule of five: | Accepted |
| Polar Surface Area: | 0.0 | Aromatic Rings: | 1 |
| Heavy Atoms: | 10 | QED Weighted: | 0.55 |
| Caco-2 Permeability: | -4.386 | MDCK Permeability: | 0.00002220 |
| Pgp-inhibitor: | 0.039 | Pgp-substrate: | 0.007 |
| Human Intestinal Absorption (HIA): | 0.005 | 20% Bioavailability (F20%): | 0.155 |
| 30% Bioavailability (F30%): | 0.943 |
| Blood-Brain-Barrier Penetration (BBB): | 0.915 | Plasma Protein Binding (PPB): | 93.67% |
| Volume Distribution (VD): | 1.951 | Fu: | 5.52% |
| CYP1A2-inhibitor: | 0.94 | CYP1A2-substrate: | 0.947 |
| CYP2C19-inhibitor: | 0.768 | CYP2C19-substrate: | 0.853 |
| CYP2C9-inhibitor: | 0.402 | CYP2C9-substrate: | 0.601 |
| CYP2D6-inhibitor: | 0.73 | CYP2D6-substrate: | 0.917 |
| CYP3A4-inhibitor: | 0.224 | CYP3A4-substrate: | 0.517 |
| Clearance (CL): | 10.462 | Half-life (T1/2): | 0.436 |
| hERG Blockers: | 0.037 | Human Hepatotoxicity (H-HT): | 0.057 |
| Drug-inuced Liver Injury (DILI): | 0.096 | AMES Toxicity: | 0.025 |
| Rat Oral Acute Toxicity: | 0.025 | Maximum Recommended Daily Dose: | 0.157 |
| Skin Sensitization: | 0.194 | Carcinogencity: | 0.336 |
| Eye Corrosion: | 0.975 | Eye Irritation: | 0.995 |
| Respiratory Toxicity: | 0.042 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC000734 | ![]() |
0.636 | D06GIP | ![]() |
0.400 | ||
| ENC000180 | ![]() |
0.594 | D05VIX | ![]() |
0.364 | ||
| ENC000552 | ![]() |
0.500 | D0X0RI | ![]() |
0.319 | ||
| ENC000407 | ![]() |
0.486 | D0S5LH | ![]() |
0.283 | ||
| ENC000649 | ![]() |
0.459 | D0X4RN | ![]() |
0.281 | ||
| ENC000413 | ![]() |
0.444 | D01PJR | ![]() |
0.280 | ||
| ENC001744 | ![]() |
0.442 | D0EL2O | ![]() |
0.274 | ||
| ENC001026 | ![]() |
0.436 | D02YYF | ![]() |
0.265 | ||
| ENC000614 | ![]() |
0.417 | D04YMH | ![]() |
0.262 | ||
| ENC000239 | ![]() |
0.400 | D0T3NY | ![]() |
0.259 | ||